Approval · Notice of Compliance 33051 · 2024
EXTRANEAL: Notice of Compliance 33051
Issued April 12, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33051
- Date
- April 12, 2024
- Company
- Vantive UlcMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in Product Ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EXTRANEAL | 02240806 | Marketed |
Medicinal ingredients
- CALCIUM CHLORIDE 257 MG per L
- MAGNESIUM CHLORIDE 51 MG per L
- SODIUM CHLORIDE 5.35 G per L
- SODIUM LACTATE 4.48 G per L
- ICODEXTRIN 75 G per L